| Hampe, Jim (IFM Therapeutics 201610 SVP Business Development + Operations + Strategy) |
Business Development Manager / Strategy Manager |
Bristol Myers Squibb (BMS) (Group) |
United States (USA) |
| Hampl, Bernhard (Formycon 201403– Advisory Board Member former CEO of Eon Labs/Sandoz US) |
Advisory Board member |
Formycon (Group) |
Germany |
| Han, Jason (SGS 201701 Managing Director of SGS Vietnam) |
Managing Director |
SGS (Group) |
Vietnam |
| Hanan, Christopher C. (Tecan 2005– Senior VP BusDev + Corporate Communications joined Tecan 2004) |
Business Development Manager / Strategy Manager |
Tecan (Group) |
Switzerland |
| Hanau, Götz (RWE 201710 Head of Strategy + Innovation at RWE Generation SE) |
Business Development Manager / Strategy Manager |
RWE (Group) |
Germany |
| Haney, Bill (Skyhawk Therapeutics 201901 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Skyhawk Therapeutics (Group) |
United States (USA) |
| Hangen, Frauke (BioRiver 201104 Managing Director) |
Managing Director |
BioRiver – Life Science im Rheinland e. V. |
Germany |
| Hanisch, Carola (CEMIT 201105 Communication Manager) |
public relations / investor relations |
CEMIT – Center of Excellence in Medicine and IT GmbH |
Austria |
| Hanke, Jeffrey (Jeff) (Tesaor 201506– CSO before Boehringer + AstraZeneca + Pfizer) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
GSK (Group) |
United States (USA) |
| Hanke, Jens |
n. a. |
Robowatch Technologies GmbH |
Germany |
| Hanke, Thomas (Evotec 202104 Head of Academic Partners joined 201311 before Novo Nordisk + TeGenero) |
Research & Development Manager |
Evotec (Group) |
Germany |
| Hanken, Thomas (Isitec 201109 Managing Director) |
Managing Director |
Isitec GmbH |
Germany |
| Hannah, David (Link Technologies 201409 Head of Marketing) |
Sales Manager / Marketing Manager |
Link Technologies Ltd. |
United Kingdom (GB) |
| Hannemann, Robert (MeVis Medical 201010– CFO) |
Chief Financial Officer (CFO) |
Varian Medical Systems (Group) |
Germany |
| Hannus, Michael (SiTools Biotech GmbH 201504 Managing Director) |
Managing Director |
siTools Biotech GmbH |
Germany |
| Hannus, Stefan (Intana Bioscience 201105 Managing Director) |
Managing Director |
Intana Bioscience GmbH |
Germany |
| Hansel, Alfred (Oncgnostics GmbH 201204 Managing Director + Co-founder) |
Managing Director |
Oncgnostics GmbH |
Germany |
| Hansen, Carl (AbCellera 201902 CEO) |
Chief Executive Officer (CEO) |
AbCellera (Group) |
Canada |
| Hansen, David (MabVax Therapeutics 201807 CEO) |
Chief Executive Officer (CEO) |
BioNTech (Group) |
United States (USA) |
| Hansen, Dirk (Phenomenex 201003 Marketing Manager Europe) |
Sales Manager / Marketing Manager |
Danaher (Group) |
Germany |
| Hansen, Fabian (ANGERMAYER Group 202012 General Partner at Presight Capital) |
General Partner (venture partner) |
ANGERMAYER Group (Apeiron Investment Group/Presight Ventures) (family of Christian Angermayer) |
Malta |
| Hansen, Gabriele (Evotec 201404 VP Corporate Communications + Investor Relations) |
Public Relations Manager / Investor Relations Manager |
Evotec (Group) |
Germany |
| Hansen, Jakob Dynnes (Acesion Pharma 201611– CFO before Evolva + Nuevolution + Zealand Pharma + Novo Nordisk) |
Chief Financial Officer (CFO) |
Evolva (Group) |
Switzerland |
| Hansen, Jørgen (Evolva 201304–201712 promoted CSO before run Danish research TO STEP DOWN unitl end 2017) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Evolva (Group) |
Switzerland |
| Hansen, Rolf (Kreatech 201008– Director Marketing & Sales before Qiagen + Beckman Coulter + Miltenyi Biotec) |
Sales Manager / Marketing Manager |
Danaher (Group) |
Netherlands |
| Hantson, Ludwig Norbert Michel (Alexion 201703– CEO before Baxalta/Baxter) |
Chief Executive Officer (CEO) |
AstraZeneca (Group) |
United States (USA) |
| Haque, Imran (Freenome 201804 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Freenome (Group) |
United States (USA) |
| Harada, Manabu (Filgen Inc 201404 Manager of Bioscience Dept) |
n. a. |
Filgen Inc. (JP) |
Japan |
| Haran, Gilad (Weizmann Institute 201604 Prof + Dean of Faculty of Chemistry) |
Professor |
Weizmann Institute of Science |
Israel |
| Harbort, Diana (Cassiopea 201507 CEO) |
Chief Executive Officer (CEO) |
Cassiopea S.p.A. (SIX: SKIN) |
Italy |
| Hardas, Bhushan (Almirall 201809 EVP RnD + CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Almirall (Group) |
Spain (España) |
| Hardenbicker, Markus (GSK 201703 Head Corporate Communications at GlaxoSmithKline GmbH & Co KG) |
Public Relations Manager / Investor Relations Manager |
GSK (Group) |
Germany |
| Harder, Alexander (Thermo Fisher 201607– Senior Platform Manger Exactive Series before Bruker Daltonik GmbH) |
Product Manager (personnel) |
Thermo Fisher (Group) |
Germany |
| Harding, Alex (CRISPR Therapeutics 202301– Head BusDev before Remix Theraepeutics + Atlas Venture) |
Business Development Manager / Strategy Manager |
CRISPR Therapeutics (Group) |
Switzerland |
| Hardung, Kerstin (Peqlab 200809) |
n. a. |
Avantor (Group) |
Germany |
| Hardwick, Andy (Schauenburg 201912 Commercial Director at Schauenburg Analytics Ltd) |
Chief Commercial Officer (CCO) |
Schauenburg (Group) |
|
| Hardwicke, David (Structured Immunity 201808 President + Co-Founder) |
n. a. |
Structured Immunity (US) |
United States (USA) |
| Hardy, David (ACD/Labs 201404 MS Product Manager before Waters UK + Shimadzu UK) |
Product Manager (personnel) |
Advanced Chemistry Development (ACD/Labs) (Group) |
United Kingdom (GB) |
| Harkins, Timothy (Swift Biosciences 201602 CEO) |
Chief Executive Officer (CEO) |
Danaher (Group) |
United States (USA) |
| Harland, Deborah (GSK 200904 Partner at SR One Ltd) |
Partner (venture partner) |
SR One (Group) |
United States (USA) |
| Harmeier, Anja (Rewind Therapeutics 202301 CEO + Bellevue 202007 Partner at Pureos Bioventures) |
Chief Executive Officer (CEO) |
Rewind Therapeutics N.V. |
Belgium |
| Harms, Carsten |
n. a. |
Eurofins (Group) |
Germany |
| Harmsen, Dag (Ridom GmbH 201307 Managing Director) |
Managing Director |
Ridom GmbH |
Germany |
| Harnest, Simon (Metagenomi 202107– Chief Investment Officer + SVP Strategy before Cellectis + Trout Group) |
Public Relations Manager / Investor Relations Manager |
Metagenomi Inc. |
United States (USA) |
| Harold, Theodora (Crescendo Biologics 201905– CEO before CFO before PsiOxus + Mission Tx + OrthoMimectics + Cytomax) |
Chief Executive Officer (CEO) |
Crescendo Biologics Ltd. |
United Kingdom (GB) |
| Harper, Sean E. (Amgen 201307 EVP RnD) |
Research & Development Manager |
Amgen (Group) |
United States (USA) |
| Harr, Steve (Sana Biotechnology 201901– CEO before Juno Therapeutics 201509 CFO + Head Corporate Development) |
Chief Executive Officer (CEO) |
Sana Biotechnology Inc. |
United States (USA) |
| Harrington-Smith, Kristen (ADC Therapeutics 202211– CCO before Immunogen + Novartis Pharmaceuticals) |
Chief Commercial Officer (CCO) |
ADC Therapeutics (Group) |
Switzerland |
| Harris, Michael (Sigma-Aldrich 201104 VP Managing Director EMEA) |
Regional manager |
Merck (DE) (Group) |
Switzerland |
| Harrison, Clark (Biocartis 201201– COO before Leica Biosystems VP Global Operations) |
Chief Operating Officer (COO) |
Biocartis (Group) |
Switzerland |
| Harrison, Tim (Almac 201506 VP Drug Discovery at Almac Discovery) |
Research & Development Manager |
Almac (Group) |
United Kingdom (GB) |
| Hart, Bradley (Thermo Fisher 201509 Strategic Director Life Sciences MS Clinical Markets) |
Product Manager (personnel) |
Thermo Fisher (Group) |
United States (USA) |
| Hart, Richard C. (Qiagen 201009 Director Human Resources Qiagen US) |
Human Resources Manager |
Qiagen (Group) |
United States (USA) |
| Hartel, Christian (Wacker 202206 CEO) |
Chief Executive Officer (CEO) |
Wacker (Group) |
Germany |
| Hartert, Daniel (Bayer 201711 Chief Information Officer) |
Chief Information Officer (CIO) / Chief Digital Officer |
Bayer (Group) |
Germany |
| Hartl, Franz-Ulrich (Max Planck 200909 Director MPI for Biochemistry Munich) |
n. a. |
Max Planck Society for the Advancement of Science |
Germany |
| Hartman, Brad (Be Biopharma 202208– Chief People Officer before FerGene + ConnectedSearch) |
Human Resources Manager |
Be Biopharma Inc. |
United States (USA) |
| Hartmann, Andreas (Greenovation Biotech 201405– CBO before Therabel + Emergent BioSolutions + Bavarian Nordic) |
Chief Business Officer (CBO) |
Eleva GmbH |
Germany |
| Hartmann, Gunther (Univ Hospital Bonn 201503 Professor + Co-founder + Board Chairman of Rigontec GmbH) |
Professor |
University of Bonn (Rheinsche Friedrich-Wilhelms-Universität Bonn) |
Germany |
| Hartmann, Hans Bodo (greenovation 200606 Managing Director) |
Managing Director |
Eleva GmbH |
Germany |
| Hartmann, Kai (Definiens 201305 Director Product Marketing Life Sciences) |
Sales Manager / Marketing Manager |
AstraZeneca (Group) |
Germany |
| Hartmann, Ute (Brandenburg (govt) 201204 Life Science team leader at Brandenburg Economic Development Board) |
Business Development Manager / Strategy Manager |
Brandenburg (govt region) |
Germany |
| Hartung, Matthias (Semalytix 202308 Managing Director + CRDO + Co-Founder) |
Managing Director |
Semalytix GmbH |
Germany |
| Hartwig, Gabriele (Sacura GmbH 201201– Managing Director before Amantec GmbH Managing Director) |
Managing Director |
Sacura GmbH |
Germany |
| Hartwig, Wolfgang (Bayer) |
n. a. |
Bayer (Group) |
Germany |
| Harvey, Lucy (QuantuMDx 201506 Business Development + Marketing Officer) |
Business Development Manager / Strategy Manager |
QuantuMDx (Group) |
United Kingdom (GB) |
| Hasan, Rafiq (Complement Therapeutics 202202– CEO before Exact Therapeutics + Bayer + Novartis) |
Chief Executive Officer (CEO) |
Complement Therapeutics (CTx) (Group) |
United Kingdom (GB) |
| Haselhuhn, Rafael (Omnilab (DE) 201511 Managing Director + Minority Owner of Opti-Lab GmbH) |
Managing Director |
Omnilab (DE) (Group) |
Germany |
| Haselsteiner, Klemens (STRABAG 202310 CEO) |
Chief Executive Officer (CEO) |
STRABAG (Group) |
Austria |
| Hasenmaier, Joachim (Boehringer 201210– Managing Director responsible for Consumer Healthcare + Animal Health) |
Managing Director |
Boehringer Ingelheim (Group) |
Germany |
| Hashemi, Brian B. (Novigenix 202211 CEO + Executive Chairman) |
Chief Executive Officer (CEO) |
Novigenix S.A. |
Switzerland |
| Hashimoto, Lara (Sophia Genetics 202004– CBO before Roche Diagnostics) |
Chief Business Officer (CBO) |
Sophia Genetics (Group) |
Switzerland |
| Hasler, Hans Peter (Élan 201210– COO before HBM Bioventures + HPH Management before Biogen Idec COO) |
Chief Operating Officer (COO) |
Élan (Group) |
Ireland, Republic of |
| Hassabis, Demis (Alphabet 202107 CEO + Co-Founder of DeepMind) |
Chief Executive Officer (CEO) |
Alphabet (formerly Google) (Group) |
United Kingdom (GB) |
| Hassan, Tolga (AgomAb Therapeutics 202103– CFO before F-Star + Johnson Matthey) |
Chief Financial Officer (CFO) |
Agomab Therapeutics (Group) |
Belgium |
| Hasselmann, Harald (Eckert & Ziegler 202306– promoted to Executive Director & Board Chair) |
Board member, executive |
Eckert & Ziegler (Group) |
Germany |
| Hasskarl, Horst |
n. a. |
AbbVie (Group) |
Germany |
| Hassler, Werner (Biotrend / Anawa Trading 201204 CEO) |
Chief Executive Officer (CEO) |
Biotrend (Group) |
Switzerland |
| Hastie, Rohan (Metabolon 201806– CEO joined 201709 as CBO before Arrow Life Sciences & Healthcare + Hologic) |
Chief Executive Officer (CEO) |
Metabolon (Group) |
United States (USA) |
| Hatano, Isao (Merck (DE) 202212 Head of Process Solutions at Merck Life Science business sector in Japan) |
President/Director/Head Business Group/Unit/Division |
Merck (DE) (Group) |
Germany |
| Hatchett, Richard (CEPI 201902 CEO) |
Chief Executive Officer (CEO) |
Coalition for Epidemic Preparedness Innovations (CEPI) |
Norway |
| Hattermann, Stefanie |
n. a. |
Omnilab (DE) (Group) |
Germany |
| Hatz, Benedikte (TeGenero 200603 CEO) |
Chief Executive Officer (CEO) |
TeGenero AG |
Germany |
| Haubner, Ralph (Axaron 200307– CFO before Boehringer Ingelheim + GD Searle + Fresenius + Biotest) |
Chief Financial Officer (CFO) |
2invest (Group) |
Germany |
| Haubner, Simone (Biosaxony 202207 Project Management Medical Technology) |
Business Development Manager / Strategy Manager |
Biosaxony Management GmbH |
Germany |
| Hauck, Gerrit (Basilea 201807– CTO before Sanofi) |
Chief Technology/Technical Officer (CTO) |
Basilea (Group) |
Switzerland |
| Hauck, Sabine (Leukocare 201904 VP RnD) |
Research & Development Manager |
Leukocare (Group) |
Germany |
| Hauck, Simone (Eppendorf 202104– Manager Coprorate Communications before Life Science Nord) |
Public Relations Manager / Investor Relations Manager |
Eppendorf (Group) |
Germany |
| Hauck, Stefanie (Helmholtz 201202 Deputy Head Research Unit Protein Science at Helmholtz-Zentrum München) |
Researcher (university / research institute) |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Hauer, Andreas (Savira Pharmaceuticals 201210– CFO before Erste Group Bank + Igeneon) |
Chief Financial Officer (CFO) |
Savira Pharmaceuticals GmbH |
Austria |
| Hauffe, Dietrich (Bruker 201508– EVP Life Sciences Mass Spectrometry at Bruker Daltonics before Qiagen + Dionex) |
President/Director/Head Business Group/Unit/Division |
Bruker (Group) |
United States (USA) |
| Haug, Matthias (Bayer 201206 Head of Seed Treatment at Bayer CropScience) |
President/Director/Head Business Group/Unit/Division |
Bayer (Group) |
Germany |
| Haug, Peter (Oncgnostics GmbH 201501 Business Development + Licensing Manager) |
Business Development Manager / Strategy Manager |
Oncgnostics GmbH |
Germany |
| Hauge, Elise (Lundbeck 201909– EVP People + Communication before SimCorp + Takeda + Nycomed) |
Human Resources Manager |
Lundbeck (Group) |
Denmark |
| Haugg, Norbert |
n. a. |
Deutsches Patent- und Markenamt |
Germany |
| Hauke, Sven (ZytoVision GmbH 200405–200902– Managing Director + founder before Alcedo Biotech) |
Managing Director |
ZytoVision (Group) |
Germany |
| Hauner, Anna (Temedica 202308 Corporate Communications) |
Public Relations Manager / Investor Relations Manager |
Temedica GmbH |
Germany |
| Haunhorst, Eberhard (Niedersachsen (govt) 201407 President of LAVES) |
Administrative Officer (personnel) |
Niedersachsen (govt region) |
Germany |
| Haupt, Joachim (PharmAI 202204 CEO) |
Chief Executive Officer (CEO) |
PharmAI GmbH |
Germany |
| Haupt, Lena (Hessen (govt) 201411 Project Manager Life Sciences at Hessen Trade & Invest) |
Cluster Manager |
Hessen (Hesse) (govt region) |
Germany |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
1 2 3 ... 28 29 30 ... 86 87 88 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
